Bloomberg Prognosis: Advancing Health Equity in Dermatology
November 29, 2022
About The Event
Strides have been made in medical dermatology to address the unique needs of communities of color. However, many patients continue to face biases in access, treatment and care. An overall lack of patients with adequate exposure to research, diversity in clinical trials and representation of darker skin tones in dermatology poses risks to Black and brown populations.
Historically, ethnically and racially diverse groups have harbored a distrust of the medical community. Misinformation and lack of workforce diversity fuels skepticism. Patients of color are also disproportionately impacted by socioeconomic obstacles and lack of visibility, which often leads to incorrect diagnosis and neglect.
The health care community must cultivate the competence needed to fight these engrained disparities. We will convene health industry leaders, researchers, practitioners and advocates for in-depth conversations on dermatological disparities and various ways to accelerate equity in dermatology.
Cheryl M. Burgess, MD, FAAD
Founder, Medical Director & President, Center for Dermatology & Dermatologic Surgery, PC
Assistant Clinical Professor at Georgetown University & The George Washington University
Seemal R. Desai, MD, FAAD
Past President of the Skin of Color Society
Founder of Innovative Dermatology, Clinical Assistant Professor of Dermatology at the University of Texas Southwestern Medical Center
U.S. Commercial Inflammation & Immunology (I&I) Lead
Jack Resneck Jr., MD
President, American Medical Association
Professor & Chair of Dermatology, UCSF
Maryam Sadeghi, Ph.D.
CEO & Co-founder
MetaOptima Technology Inc.
Susan C. Taylor, MD, FAAD
Bernett Johnson Endowed Professor of Dermatology & Vice Chair for Diversity, Equity & Inclusion for the Department of Dermatology
Perelman School of Medicine at the University of Pennsylvania